comparemela.com
Home
Live Updates
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) : comparemela.com
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, April 04, 2023 -- Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for... | April 4, 2023
Related Keywords
Massachusetts ,
United States ,
San Francisco ,
California ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Shane Kovacs ,
Olema Pharmaceuticals Inc ,
Nasdaq ,
Compensation Committee Of Olema Board Directors ,
Compensation Committee ,
Nasdaq Listing Rule ,
Olema Pharmaceuticals ,
Chief Operating ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Han ,
Pril ,
023 ,
Bulema ,
Iopharmaceutical ,
Company ,
Ocused ,
N ,
The ,
End ,
Ommercialization ,
F ,
Argeted ,
Herapies Olma Us68062p1066 ,
comparemela.com © 2020. All Rights Reserved.